MedTrace Logo

The Significance of the Mesh Thickness in the Operation of Inguinal Hernia

NCT00451893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 412

Last updated 2026-04-22

No results posted yet for this study

Summary

The trial compares the postoperative complain, pain, quality of life after the implantation of a heavy-weight alternative light-weight mesh, by randomly allocating patients with inguinal hernia disease to two groups of surgeons, each group being trained to operate with one of the above mentioned meshes.

Hypothesis: There is less postoperative pain after the implantation of a light-weight mesh.

Conditions

  • Inguinal Hernia

Interventions

PROCEDURE

Lichtenstein operation with a heavy-weight mesh

Bard flat mesh, polypropylene, 7,5 x 15 cm, 90 g/m2

PROCEDURE

Lichtenstein operation with a light-weight mesh

Johnson\&Johnson Ultrapro, polypropylene/poliglecaprone, 10 x 15 cm, 28 g/m2

Sponsors & Collaborators

  • Norrlandstingens Regionförbund

    collaborator OTHER

  • Jämtland County Council, Sweden

    collaborator OTHER_GOV

  • Västerbotten County Council, Sweden

    collaborator OTHER_GOV

  • Umeå University

    lead OTHER

Principal Investigators

  • Markku M Haapamaki, MD, PhD · Umeå University, Department of Surgical and Perioperative Sciences

  • Erik Nilsson, MD, Ph D · Umeå University, Department of Surgical and Perioperative Sciences

  • Pär Nordin, MD, PhD · Umeå University, Department of Surgical and Perioperative Sciences

  • Martin Rutegård, MD, PhD · Umeå University, Department of Surgical and Perioperative Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00451893 on ClinicalTrials.gov